ETF · JPMorgan
JXUD Global ex US Research Enhanced Index Equity Active UCITS ETF - USD
ISIN IE000QC2YB58London Stock Exchange: JXUDJPMorgan Chase & Co.
- Global shares
- ETF
- ISA
- SIPP
- Distributing
Latest close
LSE$24.95
on
- Ongoing charge
- 0.31% a year
- Fund size
- £447k
As of , at least 15 min delayed
At a glance
As of 13/11/2026, JXUD (Global ex US Research Enhanced Index Equity Active UCITS ETF - USD, ISIN IE000QC2YB58) closed at $24.95 on the London Stock Exchange. Its ongoing charge is 0.31% a year (about £31 on £10,000).
Charges compared with similar funds
- Ongoing charge
- 0.31%
- a year
- On £10,000
- £31
- a year, roughly
- Over five years
- £154
- of £10,000, before growth
- 138 charge less
- 0 the same
- 69 charge more
Ongoing charge of JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD 0.31% a year. Compared on 14/11/2026, 69 of the 207 other global share funds charge more, 0 the same and 138 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
As of
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD is an exchange-traded fund (ETF) from JPMorgan, launched in 2026.
It tracks the No Underlying Index.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.31% a year — about £31 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is paid out to holders as cash, usually a few times a year.
Global shares: Thousands of companies across many countries, held in one fund — the broadest way to own the stock market.
Key facts
- Ticker
- JXUD
- ISIN
- IE000QC2YB58
- Provider
- JPMorgan
- Tracks
- No index — the manager chooses the holdings
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Distributing, paid quarterly
- Income is paid out to holders as cash, usually a few times a year.
- Ongoing charge
- 0.31% a year · about £31 on £10,000
- Fund size
- £447k
- Launched
- Domicile
- Ireland
- UK reporting fund status
- Yes — on HMRC’s list of reporting funds (list of )
- Reporting fund since . What reporting fund status means
- Can usually be held in
- ISA and SIPP
- Check with your platform: each decides which funds it offers.
- Currency hedged
- No
- Price currency
- USD
- Category
- Global shares
Price chart
Since 26/06/2026, the closing price went from $24.67 on 26/06/2026 to $24.95 on 13/11/2026 (+1.1%). The lowest close shown was $24.55 on 23/10/2026 and the highest $26.05 on 14/08/2026.
One close a week. Before 25/08/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded. Price only — income paid out is not included.
As of , at least 15 min delayed
Five years of prices, and after inflation
17 weekly closes, from 26/06/2026 to 13/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
What it holds
- Holdings
- 286
- on record
- Ten largest
- 14.8%
- of the whole fund
- Effective number of holdings
- 144
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 2.8%
- ASML
Top 10 holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | ASMLASMLNetherlands | 2.80% |
| 2 | AstraZenecaAZNUnited Kingdom | 1.71% |
| 3 | AllianzALVGermany | 1.48% |
| 4 | SiemensSIEGermany | 1.44% |
| 5 | RocheROSwitzerland | 1.35% |
| 6 | NestleNESNSwitzerland | 1.30% |
| 7 | HSBCHSBAUnited Kingdom | 1.20% |
| 8 | ShellSHELUnited Kingdom | 1.20% |
| 9 | NovartisNOVNSwitzerland | 1.16% |
| 10 | Royal Bank of CanadaRYCanada | 1.15% |
As of , holdings as published
Where it invests
The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.
By sector
- Banks18.7%
- Industrial Cyclicals11.1%
- Pharm/MedTech9.0%
- Basic Industries8.7%
- Technology - Semi & Hardware7.5%
- Insurance7.0%
- Energy5.8%
- Consumer Staples4.7%
- Other sectors27.6%
By country
- Japan20.8%
- United Kingdom14.3%
- Canada12.4%
- France10.0%
- Germany9.6%
- Switzerland6.8%
- Australia6.0%
- Netherlands5.5%
- Other countries14.5%
By type of asset
- Equity99.8%
- Cash and money market0.2%
See the full portfolio
Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 100 largest and what changed since .
More of the portfolio
The fund publishes 286 holdings; the ten largest make up 14.8% of it. The fund's portfolio is also split by currency.
Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured
Questions people ask
What is the ongoing charge of JXUD?
The ongoing charge of JXUD is 0.31% a year — about £31 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD 0.31% a year. Compared on 14/11/2026, 69 of the 207 other global share funds charge more, 0 the same and 138 less (share classes counted once).
Is JXUD accumulating or distributing?
JXUD is distributing: income is paid out to holders as cash, usually a few times a year. It pays out quarterly.
What is the ISIN of JXUD?
The ISIN of JXUD is IE000QC2YB58. An ISIN identifies one exact share class of a fund; JXUD is its ticker on the London Stock Exchange.
What does JXUD hold?
As of 13/11/2026, JXUD holds 286 positions, according to its published holdings. The largest is ASML at 2.80% of the fund; the ten largest make up 14.8%. Its ten largest holdings are ASML (2.80%), AstraZeneca (1.71%), Allianz (1.48%), Siemens (1.44%), Roche (1.35%), Nestle (1.30%), HSBC (1.20%), Shell (1.20%), Novartis (1.16%) and Royal Bank of Canada (1.15%).
Similar funds
- SWDAiShares Core MSCI World UCITS ETF0.20% a year · £110bn
- VWRPVanguard FTSE All-World UCITS ETF Accum USD0.14% a year · £49bn
- SSACiShares MSCI All Country World UCITS ETF0.20% a year · £26bn
- VWRLVanguard FTSE All-World UCITS ETF0.14% a year · £20bn
- XWLDXtrackers MSCI World UCITS ETF0.12% a year · £18bn
- ACWIState Street SPDR MSCI All Country World UCITS ETF0.12% a year · £16bn
- SWLDState Street SPDR MSCI World UCITS ETF0.12% a year · £16bn
- MWRLAmundi Core MSCI World UCITS ETF Accum USD0.13% a year · £13bn
Fund documents and methods
- Fund documents
- Fund page at J.P. Morgan Asset Management · Key investor information document (KIID) (links checked )
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.